Send feedback

CBL p.Leu380Pro

c.1139T>C · rs1377506801 · VCV477692

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
1 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00034%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
CBL-related disorder

Computational evidence

Protein change
AlphaMissense1likely pathogenic · top 8% in CBL
REVEL0.974strongly pathogenic-leaning
SaProtLLR -16.61damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.9GERP 2.1, phastCons 1
Regional constrainto/e 1.05unconstrained · MANE · 22 kb · p 0.19 · regional, not allelic
Overall
CADD30.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00034% European (non-Finnish) · 4/1,177,152 alleles
Filtering AF 8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.00031% 5/1,610,866 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,364
European (non-Finnish)grpmax 0.00034% 294,288

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CBL
Protein
p.Leu380Pro
Coding
c.1139T>C
MANE Select
NM_005188
dbSNP
rs1377506801
Type
single nucleotide variant
Location
chr11:119278209 (GRCh38)
Gene constraint
LOEUF 0.622 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 64.27 · 34 PDB
Residue 380
the 'required for ubiquitination of spred2' region; the 'linker' region
Full CBL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cbl-p-leu380pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown